Advertisement TAPI - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


A Leading Global Supplier of Active Pharmaceutical Ingredients




With more than 70 years of experience and over $1.9 billion in annual sales, TAPI is a leading global supplier of active pharmaceutical ingredients. TAPI (Teva Active Pharmaceutical lngredients) is a stand alone business unit of Teva Pharmaceutical Industries limited.

TAPI offers a rich portfolio of over 290 active pharmaceutical ingredients with superior customer service, customised solid state specifications and unparalleled IP assets that protect your freedom of operation.

Our customers are leading generic pharmaceutical companies, who have found in TAPI a reliable and long-term supplier.

Research and development

The R&D group at TAPI boasts a dedicated team of over 600 top scientists located in seven development centres worldwide, specialising in the fields of chemical synthesis, fermentation, high potency, plant extract, synthetic peptides, vitamin D derivatives, prostaglandins, analytical and solid state research and development.

Our profound investment in research and development generates a steady flow of API products, enabling the timely introduction of pharmaceutical products to market. Owing to this cost conscious market, 40% of our R&D is dedicated to cost reduction through automation and efficiency, enabling our customers to remain competitive in the marketplace.


For over 70 years, quality has been the cornerstone upon which TAPI is built, enabling us to consistently deliver top quality products and services. Our commitment to quality is evidenced every day by our compliance with current GMP standards, as well as regular inspections by the FDA, other health authorities and customers.

Intellectual property (IP)

For over a decade TAPI has been a leader in the API industry through the Intellectual Properly (IP)
Value Proposition we offer to our customers. Our extensive IP portfolio, developed based on the innovations of the TAPI R&D group and filed and prosecuted by our in-house Patent Group, numbers over 4,500 granted patents and pending applications worldwide. Building a strong Intellectual Property Portfolio is a cornerstone of TAPI’s strategy and is one of our main differentiators in the marketplace.
Our stringent standards for Freedom to Operate opinions, coupled with over 20 years of global litigation experience, provide our customers with high confidence levels and decreased time to market.

Manufacturing and technology

Our 21 manufacturing sites employ over 4,600 professionals worldwide. TAPI equips its production facilities with cutting-edge technologies and state-of-the art computerised systems to maintain its consistently high product quality, while continuously improving productivity and reliability.

Our advanced technology and our experts in the field of solid state enable us to deliver customised particle size distribution (PSD), bulk density, specific surface area, more through process control and a variety of milling equipment. As part of an ongoing commitment to support our customers, TAPI continues to invest in building and expanding production capacities.

Customer service

The excellence of our customer service is yet another dimension of our commitment to quality.
Our global dedicated and capable customer service team, of over 30 customer service staff and 120 supply chain professionals, provides full technical and scientific support at the highest level to our customers across the globe.


TAPI – Israel
Teva Pharmaceutical Industries Ltd.,

A.P.I. Division,

P.O.Box 3190 Petah -Tiqva 49131
Tel: 972-3-9267338 Fax: 972-3-9267868

Regional sales offices:

North America
Plantex USA,

Tel: + 1-201-3434141 Fax: + 1-201-3433833

Western Europe
Plantex Chemicals BV,
Tel: + 31 346-290222 Fax: + 31 346-290296

CEE, Asia, Latin America & Africa
TAPI International,

Tel : + 34-93-467 7161 Fax: + 34-93-216 0314

Teva Pharmaceutical K.K. – API Division,
Tel: +813-5542-8971 Fax. +813-5542-8972

TAPl lnternational Office China,
Tel: + 86-10-83162606 Fax: + 86-10-51410728

Australia New Zealand
TAPl lnternational Office ANZ,
Tel: + 61-3-9867 2475 Fax: + 61-3-9867 2675

TAPl lnternational Office Mexico,
Tel: + 52-728-282-9800 Fax: + 52-728-285-3429

TAPl lnternational Office Brazil,
Tel/Fax: + 55-11-5506-8670

Indian Subcontinent
TAPl lnternational Office India,
Tel: + 91-22-25705681/82 Fax: + 91-22-2570 5684

TAPI Galena- Teva Czech Industries s.r.o.,
Czech Republic,
Tel : +420-553-644-634 Fax: +420-553-644-625

TAPI’s Active Pharmaceutical Ingredients Portfolio

A full comprehensive list of all pharmaceutical drugs provided by TAPI.

5-Fluorouracil A Acyclovir, Alclomethasone Dipropionate, Allopurinol, Alprazolam, Amcinonide, Amitriptyline HCI, Amlodipine Besylate, Amoxicillin, Ampicillin Trihydrate, Anastrazole -New-, Aripiprazole -New-, Armodafinil -New-, Atenolol, Atomoxetine HCI, Atorvastatin Calcium, Atracurium Besylate, Azacitidine -New-, Azithromycin Dihydrate, Azithromycin Monohydrate, Aztreonam. B Beclomethasone Dipropionate, Betamethasone, Betamethasone Acetate, Betamethasone Dipropionate, Betamethasone Disodium Phosphate, Betamethasone Valerate, Bexarotene -New-, Bicalutamide, Bivalirudin -New-, Bleomycin Sulfate,…
Quick Contact TAPI
Quick Contact TAPI

Quick Contact TAPI
Quick Contact TAPI
Quick Contact TAPI

Contact TAPI

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact TAPI